Reports
for NATAP from the
|
7th Annual Conference of the British HIV Association (BHIVA) |
April
27-29, 2001
The Hove Centre, Brighton |
Clinical implications of intracellular protease inhibitor concentrations
M Hennessy 1 , M Barry 1 , S Clarke 2 , C Bergin 2 , S Khoo 3 , D Back 3 , FM Mulcahy 2,1 Department of Clinical Pharmacology and Therapeutics and 2 GUIDE Clinic, St James Hospital, Dublin, and 3 Department of Pharmacology, University of Liverpool
Objective:
Highly active antiretroviral therapy (HAART) still lacks sufficient potency
and durability. As viral replication takes place intra-cellularly, treatment
success may depend upon intracellular (IC) PI concentrations. We examined the
relationship between plasma and IC PI concentrations in peripheral blood lymphocytes
(PBLs) of HIV patients.
Results:
Patients receiving indinavir (IDV; n=11) and nelfinavir (NFV; n=14) were studied.
PBLs were isolated by density centrifugation, stained and counted. Plasma and
IC PI concentrations were assayed by LC/MS. AUC, time to peak (T max ) and half-life
(t 1 /2) were derived. Data were correlated with HIV plasma RNA levels. IC IDV
AUC was lower than plasma (P<0.05; 9470±2239 vs 31788±6392)
while NFV underwent a ninefold IC accumulation (P<0.05; 283251±6687
vs 31034±6911). Two patients receiving IDV had IC levels below the MEC
despite acceptable plasma levels and were unsuppressed. In contrast, two patients
with subtherapeutic plasma IDV levels had IC concentrations above the MEC and
remained suppressed (VL<50cpm). IC IDV T max was delayed compared with plasma.
IC t 1 /2 was longer, thus the mean residence time of IDV within the cell was
prolonged (P<0.05) this may contribute to efficacy despite poor IC accumulation.
Discussion:
For discordant patients, IC IDV concentrations may provide better correlation
with virological response than plasma levels. All patients on NFV remained suppressed.
This highlights marked differences between PIs with respect to IC accumulation
and pharmacokinetic behaviour and has important implications for drug penetration
into sanctuary sites and therapeutic drug monitoring. The correlation between
plasma and IC AUC was r 2 = 0.6 (P<0.05), in contrast to NRTIs.
to top > |